What is Theravance Biopharma's shares (basic)?

Theravance Biopharma (TBPH) reported shares (basic) of 51.3M in Q1 2026.

How has Theravance Biopharma's shares (basic) changed year-over-year?

Theravance Biopharma's shares (basic) increased by 3.2% year-over-year, from 49.7M to 51.3M.

What is the long-term trend for Theravance Biopharma's shares (basic)?

Over 4 years (2021 to 2025), Theravance Biopharma's shares (basic) has grown at a -7.4% compound annual growth rate (CAGR), from 273.2M to 200.7M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

Theravance Biopharma TBPH Shares (Basic)

Shares (Basic) at other companies

Zevra Therapeutics, Inc.ZVRA

58.4M+8.0%

LQD

Liquidia CorporationLQDA

88M+3.3%

Royalty PharmaRPRX

436.8M+0.3%

United TherapeuticsUTHR

43.5M-3.1%

Aurinia PharmaceuticalsAUPH

132.4M-4.7%

PrecigenPGEN

354.3M+20.6%

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$890.32M+67.5%

Enterprise value$642.72M+37.0%

P/E7.8×—

P/S8.1×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's shares (basic)?: Theravance Biopharma (TBPH) reported shares (basic) of 51.3M in Q1 2026.
How has Theravance Biopharma's shares (basic) changed year-over-year?: Theravance Biopharma's shares (basic) increased by 3.2% year-over-year, from 49.7M to 51.3M.
What is the long-term trend for Theravance Biopharma's shares (basic)?: Over 4 years (2021 to 2025), Theravance Biopharma's shares (basic) has grown at a -7.4% compound annual growth rate (CAGR), from 273.2M to 200.7M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.